`Filed: June 3, 2015
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-00545
`Patent 8,589,182
`________________
`
`JAZZ PHARMACEUTICALS, INC.’S UPDATED MANDATORY
`NOTICES PURSUANT TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
`
`Case IPR2015-00545
`Patent 8,589,182
`Patent Owner Updated Mandatory Notices
`
`
`Patent Owner hereby updates its mandatory notices concerning back-up
`
`counsel and service information pursuant to 37 C.F.R. § 42.8(b)(3)-(4).
`
`Specifically, Jazz Pharmaceuticals, Inc. updates its Mandatory Notices due
`
`to its addition of Evangeline Shih (Reg. No. 50,170) and Frank C. Calvosa (Reg.
`
`No. 69,064) as additional back-up counsel. Lead counsel, F. Dominic Cerrito, and
`
`back-up counsel, John V. Biernacki, will remain as counsel in this proceeding.
`
`Contact information for additional back-up counsel is as follows:
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Phone: (212) 849-7000
`
`Fax: (212) 849-7100
`
`Email: evangelineshih@quinnemanuel.com
`
`
`
` frankcalvosa@quinnemanuel.com
`
`
`Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito
` Reg. No. 38,100
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: June 3, 2015
`
`
`
`
`
`Case IPR2015-00545
`Patent 8,589,182
`Patent Owner Updated Mandatory Notices
`
`
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`John V. Biernacki
`Reg. No. 40,511
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Direct Tel: (216) 586-7747
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`Attorneys for Jazz Pharmaceuticals, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-00545
`Patent 8,589,182
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that JAZZ
`
`PHARMACEUTICALS, INC.’S UPDATED MANDATORY NOTICES
`
`PURSUANT TO 37 C.F.R. § 42.8(a)(3) were served on June 3, 2015 by filing this
`
`document through the Patent Review Processing System as well as e-mailing a
`
`copy to dvarughe-PTAB@skgf.com and dsterlin-PTAB@skgf.com.
`
`
`Date: June 3, 2015
`
`
`
`
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito
` Reg. No. 38,100
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`John V. Biernacki
`Reg. No. 40,511
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Direct Tel: (216) 586-7747
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`Attorneys for Jazz Pharmaceuticals, Inc.